Clinical Trial Update: OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study

View source ↗

Summary

The OxiCLEAR trial, evaluating cytokine and endotoxin adsorption with the Oxiris device for sepsis and septic shock, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Pauls Stradins Clinical University Hospital | Conditions: Sepsis, Septic Shock | Status: RECRUITING